X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
oncology (15) 15
index medicus (10) 10
adult (8) 8
aged (8) 8
female (8) 8
leukemia, myeloid, acute - therapy (8) 8
male (8) 8
middle aged (7) 7
nccn clinical practice guidelines (7) 7
treatment outcome (7) 7
acute myeloid leukemia (6) 6
aged, 80 and over (6) 6
chronic myelomonocytic leukemia (6) 6
hematology (6) 6
myelodysplastic syndromes (6) 6
bone-marrow-transplantation (5) 5
colony-stimulating factor (5) 5
leukemia, myeloid, acute - diagnosis (5) 5
myelodysplastic syndromes - diagnosis (5) 5
myelodysplastic syndromes - therapy (5) 5
retrospective studies (5) 5
young adult (5) 5
acute myelogenous leukemia (4) 4
acute myeloid-leukemia (4) 4
adolescent (4) 4
antineoplastic agents - therapeutic use (4) 4
chemotherapeutic agents (4) 4
chemotherapy (4) 4
cytogenetics (4) 4
hematology, oncology and palliative medicine (4) 4
hematopoietic stem cell transplantation (4) 4
leukemia, myeloid, acute - mortality (4) 4
multivariate analysis (4) 4
nccn guidelines (4) 4
survival (4) 4
treatment (4) 4
anemia - etiology (3) 3
cancer (3) 3
clinical trials as topic (3) 3
combined modality therapy (3) 3
cytopenias (3) 3
disease management (3) 3
hematopoietic-cell transplantation (3) 3
immunologic factors - therapeutic use (3) 3
leukemia (3) 3
prognosis (3) 3
proportional hazards models (3) 3
quality-of-life (3) 3
refractory anemia (3) 3
risk factors (3) 3
survival analysis (3) 3
transplantation, homologous (3) 3
world-health-organization (3) 3
acute promyelocytic leukemia (2) 2
adults (2) 2
age factors (2) 2
analysis (2) 2
anemia - drug therapy (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
arsenic trioxide (2) 2
clofarabine (2) 2
comorbidity (2) 2
decitabine (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
drug resistance, neoplasm (2) 2
geriatric assessment (2) 2
hematinics - therapeutic use (2) 2
hematopoietic stem cell transplantation - adverse effects (2) 2
hematopoietic stem cell transplantation - methods (2) 2
induction chemotherapy (2) 2
intensive chemotherapy (2) 2
leukemia treatment (2) 2
leukemia treatment in older patients (2) 2
leukemia, myeloid, acute - drug therapy (2) 2
leukemia, promyelocytic, acute - drug therapy (2) 2
lymphomas (2) 2
myelodysplastic syndromes - complications (2) 2
myelodysplastic syndromes - drug therapy (2) 2
myelodysplastic syndromes - genetics (2) 2
neutropenia - chemically induced (2) 2
patients (2) 2
practice guidelines as topic (2) 2
prognostic scoring system (2) 2
recurrence (2) 2
risk myelodysplastic syndrome (2) 2
socioeconomic factors (2) 2
stem-cell transplantation (2) 2
survival rate (2) 2
therapy (2) 2
thrombocytopenia (2) 2
thrombocytopenia - drug therapy (2) 2
thrombocytopenia - etiology (2) 2
thrombocytopenia - pathology (2) 2
trans-retinoic acid (2) 2
transfusion-dependent patients (2) 2
united states - epidemiology (2) 2
10-day decitabine (1) 1
1st complete remission (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FUTURE ONCOLOGY, ISSN 1479-6694, 06/2019, Volume 15, Issue 17, pp. 1989 - 1995
Aim: This study evaluated the overall survival (OS) of older patients (>= 60 years) with acute myeloid leukemia based on the intensity of treatment. Methods:... 
SURVIVAL | 1ST-LINE TREATMENT | DECITABINE | INDUCTION CHEMOTHERAPY | GERIATRIC ASSESSMENT | PHASE-II | 10-day decitabine | AZACITIDINE | CARE | frail patients | hypomethylating agents | THERAPY | acute myeloid leukemia | ONCOLOGY | older adults | overall survival | AGE
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5154 - 5154
Abstract Background: Peg-asparaginasecan cause dysregulationof pro-coagulant and anti-coagulant proteins, resulting in a significant risk of venous... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4719 - 4719
Abstract Introduction: Budd-Chiari Syndrome (BCS) is a consequence of obstruction of hepatic venous outflow tract leading to increased sinusoidal pressure,... 
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2019, Volume 19, pp. S211 - S212
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 533 - 533
Abstract Introduction: Prior studies in cancer have suggested better OS of patients treated at AC as compared to NAC. This may be related to the availability... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2017, Volume 92, Issue 8, pp. 764 - 771
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3482 - 3482
Abstract Introduction: The management of hematologic malignancy-associated VTEin patients with moderate to severe thrombocytopenia is unclear. Clinical trials... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 2621 - 2621
Abstract Background: The tumor lysis syndrome (TLS) has been reported to be common in hematologic malignancies, particularly those associated with a high... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2016, Volume 91, Issue 11, pp. E468 - E472
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 268 - 268
Abstract Introduction During initial diagnosis and therapy, patients with ALL can develop life-threatening complications such as sepsis, leukostasis,... 
Journal Article
Future oncology (London, England), 06/2019, Volume 15, Issue 17, p. 1989
This study evaluated the overall survival (OS) of older patients (≥60 years) with acute myeloid leukemia based on the intensity of treatment. This single... 
Journal Article
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 09/2013, Volume 11, Issue 9, pp. 1047 - 1055
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support... 
SURVIVAL | ONCOLOGY | CONSOLIDATION THERAPY | ADULTS | TRANS-RETINOIC ACID | INTERGROUP | AIDA | APL | CHEMOTHERAPY | ACUTE PROMYELOCYTIC LEUKEMIA | ARSENIC TRIOXIDE
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2017, Volume 92, Issue 8, pp. 764 - 771
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 1061 - 1061
Abstract Abstract 1061 Poster Board I-83 Introduction: Sapacitabine is a novel nucleoside analogue with a unique ability to cause irreparable single-strand DNA... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.